About Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company engaged in the research, development, and commercialization of human medicines. Its portfolio spans diabetes care, with insulin products such as Basaglar, Humalog, Humulin, and insulin lispro, as well as type 2 diabetes therapies including Jardiance, Trajenta, and Trulicity. The company also develops and markets treatments in areas such as oncology, immunology, and neuroscience.
Why it matters
As one of the largest publicly traded pharmaceutical companies by market capitalization, Eli Lilly is closely watched for its role in diabetes and metabolic disease treatment, where it competes with other major drugmakers. Its broad product portfolio and pipeline of investigational medicines make it a key constituent of the healthcare sector and major stock indices. Investors and traders monitor the company's clinical trial results, regulatory decisions, and product launches, which can influence its business outlook and sector sentiment.
Company site ↗